BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
September 23, 2021 09:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
September 02, 2021 09:00 ET
|
BioRestorative Therapies, Inc
Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use MELVILLE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program
August 31, 2021 09:00 ET
|
BioRestorative Therapies, Inc
Patent Issued Grants Protection for Deriving Brown Adipocytes from Brown Adipose (Fat)-Derived Stem Cells MELVILLE, N.Y., Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the...
BioRestorative Therapies Discusses Upcoming Annual Meeting of Stockholders
August 11, 2021 08:30 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 11, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
May 10, 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...